Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 6, 2009
Company updates third quarter financial results and full-year 2009 guidance
-
Nov 2, 2009
Third-generation drug-eluting stent now available in CE Mark countries
-
Oct 19, 2009
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2009, as well as guidance for...
-
Oct 9, 2009
Company to webcast its conference call on October 20. Learn how to tune in
-
Oct 6, 2009
Three models of stenting system now available for palliative treatment of malignant common bile duct strictures
-
Oct 5, 2009
Study to determine which device programming strategy best minimizes the occurrence of unnecessary therapy in ICD and CRT-D patients
-
Sep 29, 2009
Agreement will settle more than a dozen lawsuits involving intellectual property in the interventional cardiology arena
-
Sep 25, 2009
Largest randomized trial to compare the use of drug-eluting stents to bare-metal stents for AMI patients
-
Sep 23, 2009
Results support benefits of paclitaxel-eluting stents in diabetic patients
-
Sep 22, 2009
Three-year TAXUS ATLAS results show safety and efficacy advantages for Boston Scientific TAXUS Liberte Stent
-
Sep 21, 2009
Both drug-eluting stents performed well in diabetic patients
-
Sep 21, 2009
Intravascular Ultrasound (IVUS) technology designed to provide physicians a 360-degree view inside the heart and coronary vessels
-
Sep 18, 2009
PLATINUM clinical program to support FDA approval of PROMUS® Element™ Stent
-
Sep 16, 2009
Scientific symposium presentations to include clinical data on TAXUS and PROMUS stents
-
Sep 14, 2009Boston Scientific's Urology/Gynecology Business Forms Marketing Alliance with Bladder Health Network
Agreement promotes access to testing solutions for female urinary incontinence
-
Sep 10, 2009
A live webcast and replay of the September 15 healthcare conference will be available.
-
Sep 4, 2009
A live webcast and replay of the September 9 session will be available.
-
Sep 2, 2009
Findings provide additional support for PCI as a viable treatment option for patients with complex coronary anatomy
-
Sep 1, 2009
The mortality reduction trend was also observed in high-risk patients with severely reduced heart function
-
Sep 1, 2009
Results of landmark heart failure trial published by New England Journal of Medicine and presented at ESC
-
Aug 31, 2009
Dr. Ken Stein to join CRM group
-
Aug 27, 2009
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and news announcements for the European...
-
Aug 26, 2009
Statement from Pete Nicholas, Chairman of the Board, pays tribute to Sen. Kennedy's dedication to providing access to quality health care
-
Aug 24, 2009
Final results from the MADIT-CRT trial will be presented on Tuesday, September 1
-
Aug 3, 2009
A live webcast and replay of the August 5 session will be available.